Nevertheless, a defect of GK impacts first-phase insulin secretion and glucose-mediated intrinsic glucagon secretion in the pancreas, and thus alters the glucose set point in patients with T2D, a condition caused by low GSIS and elevated glucagon. The gene discussed is GK; the disease is type 2 diabetes mellitus.